IRIS
MEROLA, Elettra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.496
SA - Sud America 1.522
AS - Asia 1.473
EU - Europa 280
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 9.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.407
BR - Brasile 1.238
VN - Vietnam 534
SG - Singapore 329
HK - Hong Kong 223
CN - Cina 144
AR - Argentina 137
ID - Indonesia 59
EC - Ecuador 50
DE - Germania 49
BD - Bangladesh 43
RU - Federazione Russa 43
MX - Messico 41
GB - Regno Unito 39
IN - India 32
CA - Canada 27
PY - Paraguay 27
ZA - Sudafrica 26
CO - Colombia 25
IT - Italia 25
IQ - Iraq 21
FR - Francia 17
UA - Ucraina 17
AT - Austria 15
FI - Finlandia 14
CL - Cile 12
MA - Marocco 11
PE - Perù 11
PL - Polonia 11
PK - Pakistan 10
SE - Svezia 10
TN - Tunisia 10
VE - Venezuela 10
UZ - Uzbekistan 9
EG - Egitto 8
ES - Italia 8
JP - Giappone 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
TR - Turchia 7
JO - Giordania 6
NL - Olanda 6
KE - Kenya 5
NP - Nepal 5
OM - Oman 5
UY - Uruguay 5
DZ - Algeria 4
ET - Etiopia 4
LT - Lituania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
IL - Israele 3
RS - Serbia 3
BB - Barbados 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IE - Irlanda 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.851
Salva come PNG Salva come JPEG
Città #
Dallas 6.040
Ho Chi Minh City 221
Hong Kong 219
Hanoi 114
Ashburn 105
São Paulo 94
Beijing 74
Singapore 71
Los Angeles 50
Rio de Janeiro 45
New York 28
Buenos Aires 26
Brasília 25
Haiphong 21
Curitiba 20
Campinas 18
Belo Horizonte 17
Munich 17
Quito 17
Montreal 14
Thái Bình 14
Caxias do Sul 13
Guayaquil 13
Mexico City 13
Fortaleza 12
Guarulhos 12
Hải Dương 12
Johannesburg 12
Porto Alegre 12
Santa Clara 12
Uberlândia 12
Biên Hòa 11
Düsseldorf 11
Goiânia 11
Juiz de Fora 11
Warsaw 11
Asunción 10
Buffalo 10
Da Nang 10
Ninh Bình 10
Niterói 10
Osasco 10
Turku 10
Atlanta 9
Bắc Giang 9
Dhaka 9
Orem 9
Piracicaba 9
Poplar 9
Ribeirão Preto 9
Salvador 9
Baghdad 8
Contagem 8
Frankfurt am Main 8
Jakarta 8
Manchester 8
Stockholm 8
Thái Nguyên 8
Tokyo 8
Vienna 8
Americana 7
Córdoba 7
Ha Long 7
Ipatinga 7
Lima 7
Manaus 7
Marília 7
Nuremberg 7
Passo Fundo 7
Phoenix 7
Santa Maria 7
São Bernardo do Campo 7
São José 7
Amman 6
Boston 6
Cape Town 6
Chicago 6
Ciudad del Este 6
Cotia 6
Duque de Caxias 6
Lauterbourg 6
Londrina 6
Maceió 6
Montes Claros 6
Palmas 6
Sumaré 6
Tashkent 6
Tianjin 6
Uberaba 6
Alvorada 5
Aracaju 5
Bogotá 5
Can Tho 5
Caçapava 5
Chennai 5
Formosa 5
Houston 5
London 5
Phủ Lý 5
Quảng Ngãi 5
Totale 7.884
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations 560
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 341
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 337
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 334
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 324
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 320
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 317
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 317
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 315
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 313
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 312
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 306
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 305
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 302
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 301
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 299
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 296
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 290
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 284
Curative resection in digestive neuroendocrine neoplasms: Recurrence-free survival rate and definition of a risk score for recurrence 244
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 243
- Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015 171
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 97
P53 and the malignant progression of Barrett's esophagus 78
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 76
ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors 75
Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker? 73
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting 72
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience 71
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis 70
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 68
Appendiceal collision tumors: case reports, management and literature review 67
Commentary: Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis 65
Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors 62
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 61
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome 60
Portosystemic encephalopathy in an 86-year-old patient : a clinical challenge 60
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 58
Nasogastric or nasointestinal feeding in severe acute pancreatitis 57
Role of impaired epithelial barrier of esophageal body and of proximal reflux in the pathophysiology of non-erosive gastroesophageal reflux disease 56
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications 55
Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis 53
Functional Imaging Tests versus Computed Tomography Scan: Detection of New Metastases and Clinical Usefulness in Digestive Neuroendocrine Neoplasms Follow-Up 53
Neuroendocrine tumors 53
Two-devices-in-one-channel technique for precut sphincterotomy 52
Pre-Endoscopy real-time PCR testing for SARS-CoV2 does not reduce health care workers infection and is associated with a higher reduction of endoscopic activity in an outpatient setting 51
Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements 51
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 50
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 50
Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts 50
Sequential Therapies in Well-Differentiated Gastrointestinal Neuroendocrine Tumors G3 (NET G3): Platinum-Based vs. Platinum-Free Regimens 49
Hepatitis C virus burden: Treating and educating people without prejudice 49
Efficacy and Toxicity of 5-Fluorouracil-Oxaliplatin in Gastroenteropancreatic Neuroendocrine Neoplasms 49
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives 49
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent 48
Device-assisted enteroscopy: Are we ready to dismiss the spiral? 47
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres 47
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 46
ENDOSCOPIC DIAGNOSIS OF NEUROENDOCRINE NEOPLASMS: A REAL-WORLD EXPERIENCE 46
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) 46
Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective 46
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? 46
Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis 45
TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE 45
Molecular Pathology of Pancreatic Endocrine Tumors 45
DIAGNOSTICS OF HEREDITARY COLORECTAL CANCER SYNDROMES: A REAL-WORLD EXPERIENCE 44
Role of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding 43
Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature 43
Probiotics and severe acute pancreatitis 43
Digestive neuroendocrine neoplasms: A 2016 overview 42
Treatment of Pancreatic Neuroendocrine Tumors 42
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options 41
Optimal timing of endoscopy for acute upper gastrointestinal bleeding: a systematic review and meta-analysis 39
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 39
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21 waf-1, p27, and PCNA in Barrett's esophagus 39
Probiotics and severe acute pancreatitis. Addendum 38
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 38
Recurrence rates after piecemeal endoscopic mucosal resection of large colorectal laterally spreading tumors 37
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome 37
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? 35
PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy 26
Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence 23
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults 14
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 6
Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management 4
Glucose-6-Phosphate Dehydrogenase Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study 4
Totale 9.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025944 0 0 0 0 0 0 0 0 0 749 97 98
2025/20269.011 325 3.316 3.510 1.584 245 31 0 0 0 0 0 0
Totale 9.955